Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 458 JPY 2.46% Market Closed
Market Cap: 35.4B JPY
Have any thoughts about
Fuji Pharma Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Fuji Pharma Co Ltd stock under the Base Case scenario is 2 002.38 JPY. Compared to the current market price of 1 458 JPY, Fuji Pharma Co Ltd is Undervalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
2 002.38 JPY
Undervaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Fuji Pharma Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Fuji Pharma Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Fuji Pharma Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Fuji Pharma Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Fuji Pharma Co Ltd

Provide an overview of the primary business activities
of Fuji Pharma Co Ltd.

What unique competitive advantages
does Fuji Pharma Co Ltd hold over its rivals?

What risks and challenges
does Fuji Pharma Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Fuji Pharma Co Ltd.

Provide P/S
for Fuji Pharma Co Ltd.

Provide P/E
for Fuji Pharma Co Ltd.

Provide P/OCF
for Fuji Pharma Co Ltd.

Provide P/FCFE
for Fuji Pharma Co Ltd.

Provide P/B
for Fuji Pharma Co Ltd.

Provide EV/S
for Fuji Pharma Co Ltd.

Provide EV/GP
for Fuji Pharma Co Ltd.

Provide EV/EBITDA
for Fuji Pharma Co Ltd.

Provide EV/EBIT
for Fuji Pharma Co Ltd.

Provide EV/OCF
for Fuji Pharma Co Ltd.

Provide EV/FCFF
for Fuji Pharma Co Ltd.

Provide EV/IC
for Fuji Pharma Co Ltd.

Show me price targets
for Fuji Pharma Co Ltd made by professional analysts.

What are the Revenue projections
for Fuji Pharma Co Ltd?

How accurate were the past Revenue estimates
for Fuji Pharma Co Ltd?

What are the Net Income projections
for Fuji Pharma Co Ltd?

How accurate were the past Net Income estimates
for Fuji Pharma Co Ltd?

What are the EPS projections
for Fuji Pharma Co Ltd?

How accurate were the past EPS estimates
for Fuji Pharma Co Ltd?

What are the EBIT projections
for Fuji Pharma Co Ltd?

How accurate were the past EBIT estimates
for Fuji Pharma Co Ltd?

Compare the revenue forecasts
for Fuji Pharma Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Fuji Pharma Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Fuji Pharma Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Fuji Pharma Co Ltd compared to its peers.

Compare the P/E ratios
of Fuji Pharma Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Fuji Pharma Co Ltd with its peers.

Analyze the financial leverage
of Fuji Pharma Co Ltd compared to its main competitors.

Show all profitability ratios
for Fuji Pharma Co Ltd.

Provide ROE
for Fuji Pharma Co Ltd.

Provide ROA
for Fuji Pharma Co Ltd.

Provide ROIC
for Fuji Pharma Co Ltd.

Provide ROCE
for Fuji Pharma Co Ltd.

Provide Gross Margin
for Fuji Pharma Co Ltd.

Provide Operating Margin
for Fuji Pharma Co Ltd.

Provide Net Margin
for Fuji Pharma Co Ltd.

Provide FCF Margin
for Fuji Pharma Co Ltd.

Show all solvency ratios
for Fuji Pharma Co Ltd.

Provide D/E Ratio
for Fuji Pharma Co Ltd.

Provide D/A Ratio
for Fuji Pharma Co Ltd.

Provide Interest Coverage Ratio
for Fuji Pharma Co Ltd.

Provide Altman Z-Score Ratio
for Fuji Pharma Co Ltd.

Provide Quick Ratio
for Fuji Pharma Co Ltd.

Provide Current Ratio
for Fuji Pharma Co Ltd.

Provide Cash Ratio
for Fuji Pharma Co Ltd.

What is the historical Revenue growth
over the last 5 years for Fuji Pharma Co Ltd?

What is the historical Net Income growth
over the last 5 years for Fuji Pharma Co Ltd?

What is the current Free Cash Flow
of Fuji Pharma Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Fuji Pharma Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Fuji Pharma Co Ltd

Current Assets 41.8B
Cash & Short-Term Investments 2.7B
Receivables 17.6B
Other Current Assets 21.5B
Non-Current Assets 46.6B
Long-Term Investments 8.2B
PP&E 21.2B
Intangibles 10.5B
Other Non-Current Assets 6.8B
Current Liabilities 34.6B
Accounts Payable 6.1B
Accrued Liabilities 498m
Short-Term Debt 13.5B
Other Current Liabilities 14.4B
Non-Current Liabilities 9B
Long-Term Debt 6.5B
Other Non-Current Liabilities 2.5B
Efficiency

Earnings Waterfall
Fuji Pharma Co Ltd

Revenue
44.6B JPY
Cost of Revenue
-27.1B JPY
Gross Profit
17.5B JPY
Operating Expenses
-13.8B JPY
Operating Income
3.7B JPY
Other Expenses
2.7B JPY
Net Income
6.4B JPY

Free Cash Flow Analysis
Fuji Pharma Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Fuji Pharma Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
48/100
Profitability
Score

Fuji Pharma Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Fuji Pharma Co Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
Short-Term Solvency
61/100
Solvency
Score

Fuji Pharma Co Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Fuji Pharma Co Ltd

Wall Street analysts forecast Fuji Pharma Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Fuji Pharma Co Ltd is 2 030.31 JPY with a low forecast of 2 000.81 JPY and a high forecast of 2 100 JPY.

Lowest
Price Target
2 000.81 JPY
37% Upside
Average
Price Target
2 030.31 JPY
39% Upside
Highest
Price Target
2 100 JPY
44% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Fuji Pharma Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Fuji Pharma Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

35.4B JPY

Dividend Yield

2.91%

Description

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Contact

TOKYO-TO
Chiyoda-ku
6F, Seito Kaikan, 5-7, Samban-cho
+81335563344.0
www.fujipharma.jp

IPO

1995-06-22

Employees

1 532

Officers

President & CEO
Mr. Takayuki Iwai
VP, Executive Officer & Director
Mr. Toyoyuki Kamide
Managing Executive Officer & GM of Corporate Division
Mr. Seiichi Inoue
Managing Executive Officer
Takeshi Sato
Managing Executive Officer & SCM Manager
Atsushi Mitsuhashi

See Also

Discover More
What is the Intrinsic Value of one Fuji Pharma Co Ltd stock?

The intrinsic value of one Fuji Pharma Co Ltd stock under the Base Case scenario is 2 002.38 JPY.

Is Fuji Pharma Co Ltd stock undervalued or overvalued?

Compared to the current market price of 1 458 JPY, Fuji Pharma Co Ltd is Undervalued by 27%.

Back to Top